Profile - Recent

profileDapAd&PG=MSPGEN&AP=1089300250 Profile-Public-Combined-page1|SCPProfilesocial.msn.comProfileen-usProfilesocial.msn.com/profile/default.aspxsocial.msn.com/profile/default.aspx?urlName=XvBIU72f2PmBu34x84eB21K7SHTQqX01V&mkt=en-us0Public profileProfileProfileProfile Please type a nickname.There was an error. Please try again later.3bf4b3faa8984ec5b74336f4195d5b7eFalse moreen-US
Welcome, vireoz

User Contribution Statistics

Total number of posts:3
Board Posts
0
Comments
3
Reviews
0
Joined on 11/9/2011

Advertisement



Contribution Navigation Menu

Profile pagination controls


Top StocksCOMMENT

13 biotech stock predictions for 2013

Adam takes credit for getting #7 right, but the easing of leucovorin had little effect on Spectrum's sales of Fusilev. They continue to make piles of money from the drug. However, Adam's very misleading and slanted articles on the company do continue to give succor to the shorts, and shares have been unfairly hurt as a...more
1/3/2013
Bill FleckensteinCOMMENT

A silver opportunity in a beaten miner?

So the "bad news has been fully discounted but no potential good news has been." So you'd prefer that the good news be discounted as well? Does proof-reading exist any more?
8/19/2012
Top StocksCOMMENT

Itau profits leave US banks in the dust

I'm a big fan of Jim Jubak's articles. However, it appears to me that the content of this one is largely taken from a Joe Leahy article in the Financial Times of Nov 6. That is fine, but proper attribution would be the order of the day.
11/9/2011
To report abusive content:
  1. Select the post to go to the related message board page.
  2. Under the offensive post, click Report Abuse.
  3. Fill out the form and click Report.